Cochrane Abstracts
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Once Versus Twice Daily Low Molecular Weight Heparin for the Initial Treatment of Venous Thromboembolism." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433574/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism. Accessed 02 October 2023.
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433574/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism. Accessed October 2, 2023.
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433574/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism
Once Versus Twice Daily Low Molecular Weight Heparin for the Initial Treatment of Venous Thromboembolism [Internet]. In: Cochrane Abstracts. [cited 2023 October 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433574/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
ID - 433574
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433574/all/Once_versus_twice_daily_low_molecular_weight_heparin_for_the_initial_treatment_of_venous_thromboembolism
DB - Evidence Central
DP - Unbound Medicine
ER -
